Interchange Capital Partners, LLC Astrazeneca PLC Transaction History
Interchange Capital Partners, LLC
- $279 Million
- Q3 2024
A detailed history of Interchange Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Interchange Capital Partners, LLC holds 3,008 shares of AZN stock, worth $214,289. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,008
Previous 3,079
2.31%
Holding current value
$214,289
Previous $240,000
2.5%
% of portfolio
0.08%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,335Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.48 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.99 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.65 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.62 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.36 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...